EW
Edwards Lifesciences Corp
85.70$
-1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21.9% | 19.8% | 21.8% | 21.5% | 19.4% | 21.1% | 21.3% | 22.4% | 22.2% | 21.7% | 21.8% | 22.4% | 22.0% | |
| 78.1% | 80.2% | 78.2% | 78.5% | 80.6% | 78.9% | 78.7% | 77.6% | 77.9% | 78.3% | 78.2% | 77.6% | 78.0% | |
| 19.5% | 19.1% | 19.3% | 19.7% | 18.7% | 19.6% | 18.0% | 18.0% | 18.1% | 17.1% | 16.0% | 16.0% | 16.7% | |
| 35.4% | 37.8% | 36.8% | 32.5% | 31.1% | 35.5% | 33.0% | 32.8% | 33.1% | 38.4% | 31.7% | 32.2% | 33.8% | |
| 50.2% | 52.0% | 51.5% | 52.2% | 54.7% | 56.4% | 50.7% | 49.5% | 50.5% | 54.7% | 47.0% | 47.7% | 49.9% | |
| 27.9% | 28.2% | 26.7% | 26.3% | 25.9% | 22.6% | 27.9% | 28.1% | 27.4% | 23.6% | 31.2% | 29.8% | 28.1% | |
| – | 2.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 31.2% | 29.0% | 27.9% | 27.9% | 29.7% | 28.1% | 30.7% | 26.1% | 22.4% | 5.8% | 27.8% | 29.9% | 21.8% | |
| 4.2% | 2.7% | 3.5% | 1.5% | 3.0% | 3.3% | 5.0% | 4.2% | 3.6% | 1.7% | 4.7% | 16.0% | 6.7% | |
| 31.0% | 29.2% | 26.5% | 26.2% | 226.7% | 27.8% | 25.3% | 21.5% | 18.7% | 5.8% | 23.1% | 13.9% | 15.4% | |
| 34.1% | 31.9% | 30.8% | 30.8% | 31.7% | 34.9% | 33.3% | 26.1% | 25.0% | 8.5% | 30.3% | 29.8% | 23.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.